Synovial sarcoma (SS) constitutes an aggressive tissue sarcoma that can affect all age groups but is frequently observed in children and adolescents. Although a multimodal strategy with surgery, chemotherapy and radiotherapy tends to be the treatment of choice, adequate risk stratification has allowed to separate a low-risk group of SS, with long term survival with an exclusive surgical approach. We report a case of a pediatric patient with a low-risk foot SS, that achieved prolonged event free survival and overall survival with exclusive surgical treatment, minimizing long-term morbidity of chemo and radiotherapy.